Unknown

Dataset Information

0

A narrative review of the pharmaceutical management of osteoporosis.


ABSTRACT:

Background and objective

Osteoporosis is a skeletal disorder classified by the loss of bone density in older adults leading to compromised bone strength and an increased risk of fracture. It can be divided into categories based on its etiology: senile, post-menopausal, and secondary osteoporosis. Specific prevention measures and treatments exist for targeting bone loss. Here we review and summarize the literature regarding the presentation of osteoporosis and discuss pharmaceutical therapies.

Methods

PubMed and Google Scholar were searched for articles published in English between 1980 and 2021. Search terms combined "senile osteoporosis", "osteoporosis treatment", "osteoporosis", "bisphosphonates", "denosumab", types of hormone therapy, and other relevant keywords used in various combinations.

Key content and findings

Osteoporosis affects millions but often goes undiagnosed until a pathologic fracture. Dual-energy X-ray absorptiometry (DEXA) scans evaluate bone mineral density (BMD) and are a diagnostic tool for osteoporosis. Adults over the age of 65, post-menopausal women, and those with risk factors such as previous fractures are recommended to receive DEXA scans every one to two years. Bisphosphonates, denosumab, and hormonal therapies are among the most common pharmacologic treatments for osteoporosis.

Conclusions

Daily, orally administered bisphosphonates are the first-line therapy for osteoporosis given their efficacy in decreasing fracture risk and favorable safety profile. Denosumab is an alternative that is administered subcutaneously every six months and may be given as initial therapy to select patients. Hormonal therapies are used if patients cannot tolerate bisphosphonates or denosumab or are refractory to these medications. Preventative measures for osteoporosis include tailored exercise and sufficient intake of calcium and vitamin D via diet or supplementation.

SUBMITTER: Patel D 

PROVIDER: S-EPMC10929303 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature

altmetric image

Publications

A narrative review of the pharmaceutical management of osteoporosis.

Patel Devon D   Gorrell Courtney C   Norris Jordan J   Liu Jiayong J  

Annals of joint 20230620


<h4>Background and objective</h4>Osteoporosis is a skeletal disorder classified by the loss of bone density in older adults leading to compromised bone strength and an increased risk of fracture. It can be divided into categories based on its etiology: senile, post-menopausal, and secondary osteoporosis. Specific prevention measures and treatments exist for targeting bone loss. Here we review and summarize the literature regarding the presentation of osteoporosis and discuss pharmaceutical thera  ...[more]

Similar Datasets

| S-EPMC10980676 | biostudies-literature
| S-EPMC8799550 | biostudies-literature
| S-EPMC9852145 | biostudies-literature
| S-EPMC8339754 | biostudies-literature
| S-EPMC10502549 | biostudies-literature
| S-EPMC11538845 | biostudies-literature
| S-EPMC8039643 | biostudies-literature
| S-EPMC12774982 | biostudies-literature
| S-EPMC10999020 | biostudies-literature
| S-EPMC9641060 | biostudies-literature